¼¼°èÀÇ ¸»ÃÊ µ¿¸Æ Áúȯ ½ÃÀå º¸°í¼­ : À¯Çü, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2024-2032³â)
Peripheral Artery Disease Market Report by Type, End User, and Region 2024-2032
»óǰÄÚµå : 1541208
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 146 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,339,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,786,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 7,233,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è ¸»Ãʵ¿¸ÆÁúȯ ½ÃÀå ±Ô¸ð´Â 2023³â 46¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ¾ÕÀ¸·Î IMARC GroupÀº 2024³âºÎÅÍ 2032³â±îÁö 5.2%ÀÇ ¼ºÀå·ü(CAGR)À» º¸À̸ç, 2032³â¿¡´Â 74¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.

¸»ÃÊ µ¿¸Æ Áúȯ(PAD)Àº µ¿¸ÆÀÇ ¼öÃà¿¡ ÀÇÇØ »çÁöÀÇ Ç÷·ù°¡ Á¦ÇѵǴ ½ÉÇ÷°ü°è ÁúȯÀÔ´Ï´Ù. ±× °á°ú, Å»¸ð, ´Ù¸®ÀÇ ¸¶ºñ, ´Ù¸®¿Í ¹ß°¡¶ôÀÇ ¿°Áõ, ¾ûµ¢ÀÌ¿Í ´ëÅðºÎÀÇ ÅëÁõÀ» µ¿¹ÝÇÑ °æ·Ã, ´Ù¸®ÀÇ Â÷°¡¿ò°ú ¸ÆÀÇ ¾àÁ¡, ³²¼ºÀÇ ¹ß±â ºÎÀüÀÌ ¹ß»ýÇÕ´Ï´Ù. ½ÉÀå¿¡¼­ ÆÈ°ú ´Ù¸®·Î »ê¼Ò¿Í ¿µ¾çÀÌ Ç³ºÎÇÑ Ç÷¾×À» ¿î¹ÝÇÏ´Â ´Ù¸®ÀÇ µ¿¸Æ¿¡, ¾ÆÅ×·Ò¼º µ¿¸Æ°æÈ­ÁõÀ¸·Îµµ ¾Ë·ÁÁø ÇöóÅ©°¡ ¹ß»ýÇÏ´Â °ÍÀ¸·Î ¹ßº´ÇÕ´Ï´Ù. ´Ù¸® °üÀý »ó¿Ï Ç÷¾Ð ºñÀ², ÃÊÀ½ÆÄ °Ë»ç, Ç÷°ü Á¶¿µ¼ú, Ç÷¾× °Ë»ç, µµÇ÷¯ ¹× ÃÊÀ½ÆÄ(µàÇ÷º½º) À̹ÌÁö, ÄÄÇ»ÅÍ ´ÜÃþ ÃÔ¿µ(CT), Àڱ⠰ø¸í Ç÷°ü Á¶¿µ¼ú(MRA) µîÀ» »ç¿ëÇÏ¿© Áø´ÜµË´Ï´Ù.

¸»ÃÊ µ¿¸Æ Áúȯ ½ÃÀå µ¿Çâ :

ÇöÀç Àü ¼¼°èÀûÀ¸·Î ³ë³â Àα¸°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. À̰ÍÀº °³ÀÎÀÇ ¶óÀÌÇÁ ½ºÅ¸ÀÏ º¯È­, °Ç°­¿¡ ÇØ·Î¿î ½Ä»ç ÆÐÅÏ Áõ°¡, ¾ËÄÚ¿Ã Áßµ¶, ¿îµ¿ ºÎÁ·À¸·Î ÀÎÇÑ ºñ¸¸ µî°ú ÇÔ²² ½ÃÀåÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ, ¼ö¼ú ÈÄ ÅëÁõÀÌ Àû°í, ¼ö¼ú ÈÄ ¹× ¼ö¼ú ÈÄ ÇÕº´ÁõÀÌ Àû°í, ÀÔ¿ø ±â°£ÀÌ Âª°í, ȸº¹ÀÌ ºü¸£°í, ¸é¿ª°è¿¡ ºÎ´ãÀÌ ÀûÀº µîÀÇ ÀÌÀ¯·Î, Àú ħ½À ¼ö¼ú(MIS)ÀÇ Ã¤¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. À̰ÍÀº ÀÇ·á »ê¾÷ÀÇ È®´ë¿Í ÇÔ²² ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀϺΠ±¹°¡ÀÇ Á¤ºÎ´Â PAD ÀåÄ¡ÀÇ ÀåÁ¡¿¡ ´ëÇÑ ÀνÄÀ» ³ÐÈ÷±â À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ÀÌ ¿Ü¿¡µµ ¼¼°è °³ÀÎµé »çÀÌ¿¡¼­ ½ÉÀå ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç ¾÷°è ÅõÀÚÀڵ鿡°Ô À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ½ÃÀå ±â¾÷Àº PAD Ä¡·á ´É·ÂÀ» °­È­Çϱâ À§ÇØ ÇÕº´ Àμö(M&A)¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¾÷µéÀº ¶ÇÇÑ Àü¹ÝÀûÀÎ ¼öÀͼºÀ» °­È­ÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ´Ù¾çÇÑ °³¹ß Àü·«¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

Á¦5Àå ¼¼°èÀÇ ¸»Ãʵ¿¸ÆÁúȯ ½ÃÀå

Á¦6Àå ½ÃÀå ºÐ¼® : À¯Çüº°

Á¦7Àå ½ÃÀå ³»¿ª: ÃÖÁ¾ »ç¿ëÀÚº°

Á¦8Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦9Àå SWOT ºÐ¼®

Á¦10Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦11Àå Porter's Five Forces ºÐ¼®

Á¦12Àå °¡°Ý ºÐ¼®

Á¦13Àå °æÀï ±¸µµ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global peripheral artery disease market size reached US$ 4.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032.

Peripheral artery disease (PAD) is a cardiovascular disorder wherein constricted arteries restrict blood flow to the limbs. It results in hair loss, leg numbness, feet or toe sores, painful cramps in hips and thighs, coldness and weak pulse in legs, and erectile dysfunction among men. It is caused when a plaque, also known as atherosclerosis, develops in leg arteries that carry oxygen and nutrient-rich blood from the heart to the arms and legs. It is diagnosed using the ankle-brachial index, ultrasound scan, angiography, blood tests, doppler and ultrasound (duplex) imaging, computed tomographic angiography (CT), and magnetic resonance angiography (MRA).

Peripheral Artery Disease Market Trends:

At present, there is a rise in the geriatric population across the globe. This, along with changing lifestyles of individuals, increasing adoption of unhealthy dietary patterns, alcoholism, and obesity on account of lack of physical activities, represents one of the key factors driving the market. Moreover, there is an increase in the adoption of minimally invasive surgeries (MIS) due to less postoperative pain, fewer operative and major postoperative complications, shortened hospital stay, faster recovery times, and less stress on the immune system. This, coupled with the expanding healthcare industry, is propelling the growth of the market. In addition, governments of several countries are undertaking initiatives to spread awareness about the benefits of PAD devices, which is positively influencing the market. Besides this, the rising prevalence of cardiac diseases among individuals around the world is offering lucrative growth opportunities to industry investors. Furthermore, key market players are focusing on mergers and acquisitions (M&A) to strengthen PAD treatment capabilities. These players are also focusing on various developmental strategies, which are projected to bolster their overall profitability.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global peripheral artery disease market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type and end user.

Breakup by Type:

Peripheral Angioplasty Balloons

Peripheral Stents

Peripheral Catheters

Inferior Vena Cava (IVC) Filters

Plaque Modification Devices

Hemodynamic Flow Alteration Devices

Peripheral Accessories

Breakup by End User:

Hospitals

Specialty Clinics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AngioDynamics, B. Braun Melsungen AG, Becton Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC, Koninklijke Philips N.V., Medtronic plc and Terumo Corporation.

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Peripheral Artery Disease Market

6 Market Breakup by Type

7 Market Breakup by End User

8 Market Breakup by Region

9 SWOT Analysis

10 Value Chain Analysis

11 Porters Five Forces Analysis

12 Price Analysis

13 Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â